Macular Degeneration (amd) And Diabetic Retinopathy Drugs Market

Macular Degeneration (AMD) and Diabetic Retinopathy Pharmaceutical Market 2010-2025

- what does the future hold for drugs to treat those disorders?

Our new report examines current and future prospects for the age-related macular degeneration (AMD) and diabetic retinopathy (DR) pharmaceutical markets. The global market for AMD and DR drugs exceeded $2.5bn in 2009, with growth from previous years. We predict that the overall market will expand from 2010 onwards. The rising prevalence of AMD and DR is due to aging populations worldwide and other changes. In particular, the world is facing a "diabetes epidemic", with soaring numbers of people with diabetes and related complications, including diabetic retinopathy. ( http://www.bharatbook.com/detail.asp?id=149091&rt=Macular-Degeneration-AMDand-Diabetic-Retinopathy-Pharmaceutical-Market-2010-2025.html )

In particular, Macular Degeneration (AMD) and Diabetic Retinopathy Pharmaceutical Market 2010-2025 covers market prospects for the following agents:

Lucentis

Visudyne

Macugen

Avastin.

Our report examines prospects for the retinal disorders market over the coming 15 years. The commercial success of Lucentis in treating wet AMD illustrates the high rewards for successful treatments. Our analyses reveal that there are commercial opportunities for the treatment of geographic atrophy (advanced dry AMD) and for wet AMD, among other disorders. There is a need for advantages over existing therapies, for improved clinical outcomes and ease of dosing. A large potential market for pharmacological treatment of diabetic retinopathy, AMD and other retinal disorders exists.

Un-met and under-met therapeutic needs provide an impetus to drug developers, with high technological and commercial potential in this sector, our study reveals. What impact will monoclonal antibodies and steroid implants have on the future market? Which products are most likely to meet therapeutic needs in future years? Can newer therapies compete successfully with established treatments? How will Avastin affect the market share of Lucentis, and what are the implications for the future market? Our new report covers such questions, providing the information that you need.

For more information kindly visit : http://www.bharatbook.com/detail.asp?id=149091&rt=Macular-Degeneration-AMDand-Diabetic-Retinopathy-Pharmaceutical-Market-2010-2025.html

Related Reports

Diabetic Retinopathy Therapy Area Pipeline Report

http://www.bharatbook.com/detail.asp?id=126776&rt=Diabetic-Retinopathy-Therapy-Area-Pipeline-Report.html

World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024

http://www.bharatbook.com/detail.asp?id=107335&rt=World-AMD-and-Diabetic-Retinopathy-Pharmaceutical-Market-2009-2024.html

Or

Contact us at :

Bharat Book Bureau

Tel: +91 22 27578668

Fax: +91 22 27579131

Email: info@bharatbook.com

Website: www.bharatbook.com

Follow us on twitter: http://twitter.com/3bbharatbook

Please visit our blog at http://bharatbookseo.blogsome.com

by: Bharat Book Bureau

POST COMMENT

Kuoni Travel Holding Ltd. - Swot Analysis - Market Research Reports On Aarkstore Enterprise Online Marketing: How Important Is Website Design? Aarkstore Enterprise -global Antivirals Market Analysis & Forecasts 2008-2023 Sep 2008 Spain (country regulation overview) Market Research Report Aarkstore Enterprise -Taiwan LNG Export and Import Markets to 2015- Analysis and Forecasts Fill Up Your Offers With Facebook Marketing Thomas Cook Group Plc - Swot Analysis - Market Research Reports On Aarkstore Enterprise Aarkstore Enterprise -Thailand LNG Export and Import Markets to 2015- Analysis and Forecasts Deemalls Twitter Marketing Tips And Tricks Netflix, Inc. - Swot Analysis - Market Research Reports On Aarkstore Enterprise Mobile Phone Deals : Maximum Profits At Lowest Prices Aarkstore Enterprise -oncology Market Leaders - Analyses And Outlook, Market Report 2008-2023 Parexel International Corporation - Swot Analysis - Market Research Reports On Aarkstore Enterprise